I am quite positive, currently seem to be fortunate one as have purchased a lot of shares over last two months.
My reasons are:
1) Gastric cancer is the third leading cause of cancer mortality. PAT-SC1 which has been used to treat positive gastric cancer patients in clinical trials.
2) China is one of the countries with the highest incidence of gastric cancer. Over 40% of all new gastric cancers in the world.
3) GlobalData estimates drug sales for Gastric and Gastroesophageal Junction Adenocarcinome (G/GEJAC) to be US$1.13bn in 2014 to raise to US$4.39bn in 2024
4) PAB cash on hand is approx $4m
5) joint venture with Chinese biotech (Hefei Co-source Biomedical Co LTD). China desperate to be self sufficient with pharmaceuticals and healthcare.
6) CEO has focused company on PAT-SC1, when cash starts flowing in the door they will go back to commercialising the rest of Patrys pipeline.
On negative: still very unsure why selling at 0.9 cents
- Forums
- ASX - By Stock
- PAB
- PAB Board
PAB Board, page-29
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $620 | 88.51K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 5809153 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1618945 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 5809153 | 0.006 |
16 | 7030776 | 0.005 |
7 | 4425000 | 0.004 |
5 | 2730016 | 0.003 |
2 | 4520000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1618945 | 3 |
0.008 | 2057547 | 3 |
0.009 | 133332 | 1 |
0.010 | 1592000 | 4 |
0.011 | 1080000 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |